Skip to main content
editorial
. 2022 Nov 30;16(1):133–135. doi: 10.1016/j.jiph.2022.11.030

Table 1.

Baseline clinical characteristics and causes of deaths between patients during delta variant dominant period and omicron variant dominant period.

Characteristics Total (n = 84) Delta (n = 42) Omicron (n = 42) P value
Age, years, median (IQR) 72.5 (65.0–81.0) 74.0 (66.8–82.0) 71.5 (60.8–81.0) 0.282
Male gender 57 (67.9) 27 (64.3) 30 (71.4) 0.483
Comorbidities
 Diabetes mellitus 22 (26.2) 9 (21.4) 13 (31.0) 0.321
 Hypertension 40 (47.6) 22 (52.4) 18 (42.9) 0.382
 Cardiovascular disease 23 (27.4) 10 (23.8) 13 (31.0) 0.463
 Chronic lung disease 13 (15.5) 5 (11.9) 8 (19.0) 0.365
 Liver disease 10 (11.9) 3 (7.1) 7 (16.7) 0.178
 Renal disease 15 (17.9) 9 (21.4) 6 (14.3) 0.393
 Solid cancer 31 (36.9) 13 (31.0) 18 (42.9) 0.258
 Hematologic malignancy 4 (4.8) 0 4 (9.5) 0.116
 Rheumatic disease 4 (4.8) 4 (9.5) 0 0.116
Obesity (BMI>25) 21 (25.0) 12 (28.6) 9 (21.4) 0.450
Smoking 2 (2.4) 0 2 (4.8) 0.494
Symptoms at diagnosis
 Fever 18 (21.4) 11 (26.2) 7 (16.7) 0.287
 Chill 4 (4.8) 3 (7.1) 1 (2.4) 0.616
 Cough 20 (23.8) 15 (35.7) 5 (11.9) 0.010
 Sputum 15 (17.9) 8 (19.0) 7 (16.7) 0.776
 Sore throat 5 (6.0) 3 (7.1) 2 (4.8) > 0.999
 Dyspnea 50 (59.5) 22 (52.4) 28 (66.7) 0.182
 Rhinorrhea 0 0 0 NA
 Hemoptysis 1 (1.2) 0 1 (2.4) > 0.999
 Chest pain 4 (4.8) 0 4 (9.5) 0.116
 Diarrhea 0 0 0 NA
 Headache 4 (4.8) 3 (7.1) 1 (2.4) 0.616
 Myalgia 3 (3.6) 3 (7.1) 0 0.241
 Hypogeusia 1 (1.2) 1 (2.4) 0 > 0.999
Pneumonia at admission 74 (88.1) 40 (95.2) 34 (81.0) 0.043
Severity 0.175
 Mild to moderate 19 7 12
 Severe 34 21 13
 Critical 31 14 17
Deaths 84/1020 (8.2) 42/366 (11.5) 42/654 (6.4)
 COVID-19 pneumonia 64/84 (76.2) 37/42 (88.1) 27/42 (64.3) 0.010
 Other causes 19/84 (22.6) 5/42 (11.9) 14/42 (33.3) 0.019
 Underlying disease 5 1 4
 Cardiovascular disease 6 1 5
 Bleeding 3 1 2
 Sepsis 5 2 3
 Indeterminate cause 1/84 (1.2) 0 1/42 (2.4) > 0.999

Data are presented as number (%) unless otherwise indicated. Abbreviations: BMI, body mass index; COVID-19, coronavirus disease 2019, IQR, interquartile range